Stockreport

Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019 Financial and Business Results

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF CARMIEL, Israel, March 12, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the develop [Read more]